Inhaled surfactant in patients with covid-19 who took high-flow oxygen: the results of a retrospective analysis

Inhaled surfactant in patients with covid-19 who took high-flow oxygen: the results of a retrospective analysis

The article presents a comparative retrospective analysis of clinical, laboratory data and outcomes in 39 patients with severe COVID-19 complicated by acute respiratory distress syndrome, who received high-flow oxygen therapy. Of which, 19 patients additionally received 75 mg of inhaled surfactant B...

Full description

Bibliographic Details
Main Authors:	A. V. Averyanov, T. V. Klypa, O. I. Balionis, M. V. Bychinin, A. V. Cherniak, A. V. Troitskiy, E. V. Trifonova
Format:	Article
Language:	Russian
Published:	Remedium Group LLC 2020-11-01
Series:	Медицинский совет
Subjects:	covid-19 pneumonia acute respiratory distress syndrome high-flow nasal cannula oxygen therapy surfactant
Online Access:	https://www.med-sovet.pro/jour/article/view/5879

Similar Items

Predictive factors of high-flow nasal cannula oxygen therapy failure in children with respiratory distress treated in a Pediatric Emergency Department
by: Orkun Aydın, et al.
Published: (2021-12-01)

Surfactant therapy for pneumonia COVID-19 of obstetric patients
by: M. V. Shvechkova, et al.
Published: (2022-04-01)

Risk factors contributing to weaning failure from continuous positive airway pressure to high flow nasal cannula in neonates with respiratory distress syndrome
by: Najih Rama Eka Putra, et al.
Published: (2024-02-01)

Early predictors of high-flow nasal cannula oxygen treatment failure in patients with respiratory distress admitted to the pediatric emergency department
by: Şule Demir, et al.
Published: (2022-08-01)

Evaluation of the Effects of 'High-Flow Nasal Cannula Oxygenation' Therapy on Vital Signs in Infants Diagnosed as Severe Acute Bronchiolitis Who Are Unresponsive to Conventional Therapy
by: Mücahit Koçoğlu, et al.
Published: (2020-08-01)

Preclinical Assessment of Nebulized Surfactant Delivered through Neonatal High Flow Nasal Cannula Respiratory Support
by: Francesca Ricci, et al.
Published: (2022-05-01)

Acute respiratory distress syndrome due to inhalation of acryloyl chloride
by: Takafumi Shima, et al.
Published: (2022-01-01)

High-flow nasal cannula oxygen therapy versus conventional oxygen therapy in patients undergoing bronchoscopy: a retrospective study
by: Xiaohui Luo, et al.
Published: (2024-12-01)

Modified high-flow nasal cannula for children with respiratory distress
by: Sarocha Itdhiamornkulchai, et al.
Published: (2022-03-01)

Inhaled Surfactant in the treatment of accidental Talc Powder inhalation: a new case report
by: Lo Piparo Caterina, et al.
Published: (2011-09-01)

Predictors of high-flow nasal cannula failure in pediatric patients with acute respiratory distress
by: Kantara Saelim, et al.
Published: (2022-12-01)

Successfully Treated Acute Interstitial Pneumonia
by: Marija Gomerčić Palčić, et al.
Published: (2022-01-01)

Surfactant in clinical practice /
by: Bevilacqua, Giulio, et al.
Published: (1993)

Noninvasive respiratory support via nasal cannula in premature infants: Is it really safe?
by: Mehmet Büyüktiryaki, et al.
Published: (2019-04-01)

High-flow nasal cannula oxygen therapy in the management of acute respiratory distress syndrome secondary to opioid overdose
by: Muge Gulen, et al.
Published: (2021-01-01)

Early versus late extubation after surfactant replacement therapy for respiratory distress syndrome
by: Mohamed Garib, et al.
Published: (2015-03-01)

Use of high flow nasal cannula as a modality of acute respiratory failure due to COVID-19
by: Kristin Purnama Dewi, et al.
Published: (2022-06-01)

Comparison of the Consequences of Intratracheal Administration of Surfactant Plus Budesonide with Surfactant alone in Preterm Infants with Respiratory Distress Syndrome
by: Morteza Habibi, et al.
Published: (2024-01-01)

Pulmonary Surfactants for Acute and Chronic Lung Diseases (Part I)
by: O. A. Rozenberg
Published: (2014-08-01)

High-flow nasal cannula oxygen therapy is equally effective to noninvasive ventilation for mild-moderate acute respiratory distress syndrome in patients with acute pancreatitis: A single-center, retrospective cohort study
by: Qingcheng Zhu, et al.
Published: (2024-09-01)

Nasal Cannula with Long and Narrow Tubing for Non-Invasive Respiratory Support in Preterm Neonates: A Systematic Review and Meta-Analysis
by: Pratima Anand, et al.
Published: (2022-09-01)

Evaluation of Surfactant Effects on Newborns
by: Nasrin Khalessi, et al.
Published: (2006-12-01)

High-flow nasal cannula oxygenation in comparison with apnoeic oxygenation during foreign body removal by rigid bronchoscopy: A randomised controlled trial
by: Samar M Abdel Twab, et al.
Published: (2022-01-01)

High-Flow Nasal Cannula versus Nasal Continuous Positive Airway Pres-sure in the Management of Respiratory Distress Syndrome
by: Ramin Iranpour, et al.
Published: (2011-08-01)

Surfactant therapy in late preterm infants
by: Murat Yurdakök
Published: (2013-08-01)

The experience of high-flow nasal cannula in hospitalized patients with 2019 novel coronavirus-infected pneumonia in two hospitals of Chongqing, China
by: Ke Wang, et al.
Published: (2020-03-01)

Evaluation of the therapeutic effect of high-flow nasal cannula oxygen therapy on patients with aspiration pneumonia accompanied by respiratory failure in the post-stroke sequelae stage
by: Dong Xing, et al.
Published: (2021-01-01)

Clinical studies with high flow nasal cannula oxygen delivery in 2015
by: David Sotello, et al.
Published: (2016-04-01)

Comparison of the Efficacy of Three Natural Surfactants in Preterm Turkish Newborns with Respiratory Distress Syndrome
by: Fatma Hilal Yılmaz, et al.
Published: (2021-06-01)

Indications and Safety of High Flow Nasal Cannula in Pediatric Intensive Care Unit: Retrospective Single Center Experience in Saudi Arabia
by: Asseri AA, et al.
Published: (2021-08-01)

Effectiveness and Safety of High-Flow Nasal Cannula Oxygen Delivery during Bronchoalveolar Lavage in Acute Respiratory Failure Patients
by: Eun Jin Kim, M.D., et al.
Published: (2018-10-01)

Significance of surfactant proteins in respiratory distress syndrome in preterm infants
by: İ.A. Mirzayeva, et al.
Published: (2024-04-01)

Comparing the Effects of Two Surfactant Administration Methods: Minimally Invasive Surfactant Therapy (MIST) with Intubation (INSURE) in Infants with Respiratory Distress Syndrome
by: Hassan Boskabadi, et al.
Published: (2024-10-01)

A survey of minimally invasive surfactant therapy in Canada
by: Shaily Brahmbhatt, et al.
Published: (2022-07-01)

Recent advances in the use of high flow nasal oxygen therapies
by: Kara D. Wyatt, et al.
Published: (2022-10-01)

Comparison of high flow and standard oxygen therapy in patients with acute hypoxemic respiratory failure in emergency department. A randomized controlled cross over superiority trial
by: Mamidi Rahul Rohan, et al.
Published: (2024-09-01)

COVID-19 ARDS Patients Successfully Extubated to Extubated to High-Flow Nasal Cannula Oxygen Therapy: A Retrospective Analysis
by: Gülçin Hilal Alay, et al.
Published: (2021-12-01)

Benefits and risks of noninvasive oxygenation strategy in COVID-19: a multicenter, prospective cohort study (COVID-ICU) in 137 hospitals
by: COVID-ICU group, for the REVA network, COVID-ICU investigators
Published: (2021-12-01)

Reliability of the respiratory rate and oxygenation index for successful high-flow nasal cannula support in coronavirus disease pneumonia: a retrospective cohort study
by: Ryosuke Hirabayashi, et al.
Published: (2023-08-01)

Exogenous surfactant in the late respiratory phase of COVID-19
by: K. G. Shapovalov, et al.
Published: (2021-06-01)